• Fri, March 10, 2023

Matthew Caufield Reiterated (ALDX) at Strong Buy and Held Target at $15 on, Mar 10th, 2023

Matthew Caufield of HC Wainwright & Co., Reiterated "Aldeyra Therapeutics, Inc." (ALDX) at Strong Buy and Held Target at $15 on, Mar 10th, 2023.

Matthew, nor any peers, have made any analyst calls on ALDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍